Cargando…
Therapeutic Rationale to Target Highly Expressed Aurora kinase A Conferring Poor Prognosis in Cholangiocarcinoma
Background: Cholangiocarcinoma is a highly lethal neoplasm for which the currently available chemotherapeutic agents are suboptimal. Numerous studies show that alterations in expression of genes related to mitotic spindle and mitotic checkpoint are involved in chromosomal instability and tumor progr...
Autores principales: | Ding, Xiwei, Huang, Tianlu, Peng, Chunyan, Ahn, Keun Soo, Andersen, Jesper B, Lewinska, Monika, Cao, Yu, Xu, Guifang, Chen, Gang, Kong, Bo, Friess, Helmut, Shen, Shanshan, Roberts, Lewis R, Wang, Lei, Zou, Xiaoping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052919/ https://www.ncbi.nlm.nih.gov/pubmed/32127951 http://dx.doi.org/10.7150/jca.31989 |
Ejemplares similares
-
CDK7 inhibitor THZ1 inhibits MCL1 synthesis and drives cholangiocarcinoma apoptosis in combination with BCL2/BCL-XL inhibitor ABT-263
por: Huang, Tianlu, et al.
Publicado: (2019) -
ALDH1A3 Accelerates Pancreatic Cancer Metastasis by Promoting Glucose Metabolism
por: Nie, Shuang, et al.
Publicado: (2020) -
The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells
por: Di Maira, Giovanni, et al.
Publicado: (2019) -
Lipid alterations in chronic liver disease and liver cancer
por: Paul, Bichitra, et al.
Publicado: (2022) -
Effect of rosuvastatin on outcomes in chronic haemodialysis patients – design and rationale of the AURORA study
por: Fellström, Bengt, et al.
Publicado: (2005)